Detalles de la búsqueda
1.
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
Hematol Oncol
; 39(1): 41-50, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085797
2.
Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients.
Eur J Haematol
; 104(2): 138-144, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762088
3.
New patterns of relapse in multiple myeloma: a case of "light chain escape" in which FLC predicted relapse earlier than urine and serum immunofixation.
Clin Chem Lab Med
; 54(6): 991-5, 2016 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581069
4.
Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network.
Front Oncol
; 13: 1162990, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37182182
5.
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation.
Front Med (Lausanne)
; 8: 712070, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34513878
6.
Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation.
Case Rep Hematol
; 2020: 6309736, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32509362
7.
Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study.
Clin Lymphoma Myeloma Leuk
; 21(11): e850-e852, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34344639
8.
Impact of disease status on outcome in relapsed and refractory multiple myeloma treated with lenalidomide.
Leuk Lymphoma
; 56(8): 2388-91, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25535816
9.
Daratumumab, lenalidomide, and dexamethasone combination in relapsed/refractory myeloma patients: a real-life single-center experience.
Leuk Lymphoma
; 61(13): 3255-3258, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32772601
Resultados
1 -
9
de 9
1
Próxima >
>>